Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.165 USD | +5.91% | -5.28% | +31.45% |
Jun. 04 | Top Premarket Gainers | MT |
Jun. 03 | FibroGen Investigational New Drug Application for Cancer Treatment Accepted by FDA; Regeneron Selected as Supplier | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.45% | 109M | |
+48.24% | 57.87B | |
+41.65% | 40.25B | |
-7.08% | 39.94B | |
-5.96% | 28.54B | |
+12.09% | 26.4B | |
-20.52% | 19.33B | |
+30.14% | 12.4B | |
-0.74% | 12.23B | |
+24.01% | 12.2B |
- Stock Market
- Equities
- FGEN Stock
- News FibroGen, Inc.
- Goldman Sachs Adjusts FibroGen's Price Target to $2 From $16, Keeps Sell Rating